49 THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-Y SECRETING ALLOGENEIC TUMORVACCINE